24 results for “funding”
The authors of a new Canadian study have called for increased public funding to protect the ‘scientific integrity’ of cannabis research and reduce reliance on industry sponsorship. Research led by […]
Manufactures need to take advantage of research innovation opportunities in the UK.
Alison is being forced to choose between her medication and basic needs such as food and paying the bills.
Those on the frontline say they feel optimistic about a short-term solution being reached.
The Olympian diver is supporting a cannabis-based drug trial for an aggressive form of brain cancer.
The CBD firm produces more than a dozen consumer wellness products
Online CBD marketplace Alphagreen is launching a crowdfunding campaign as it looks to sustain its growth. The platform – which claims to be the largest in Europe – allows customers to choose […]
Alphagreen – Europe’s leading marketplace for CBD and alternative healthcare products – has secured £1.1m of seed funding to help finance the roll out of new products and services alongside […]
North American body, the National Industrial Hemp Council, has received US$200,000 in U.S. Department of Agricultural (USDA) Market Access Program (MAP) funding to support export market development of industrial hemp. […]
Katie Sullivan is six months pregnant, but instead of preparing to welcome her second child into the world she is tirelessly fighting to fund the ‘life-changing’ medicine that keeps her […]
A new cannabis investment fund app has been launched to give exposure to businesses focusing on medical cannabis.
Alphagreen Group, which owns Europe’s largest consumer marketplace for legally certified cannabis products, has secured £500k in its first equity funding round.
Ask any UK cannabis clinic which conditions bring people through the door, and ADHD will reliably be near the top of the list. Despite this demand, the published literature on […]
The study is evaluating MRX1, the company’s proprietary CBD-based oral solution, as a treatment for chemotherapy-induced peripheral neuropathy (CIPN).
Germany has voted to ban medical cannabis flower from its statutory health insurance scheme.
Cannabis-derived molecules could help relieve chronic pain without the psychoactive effects associated with THC.
Ananda Pharma has taken another major step forward in bringing its flagship MRX1 CBD oral solution to market.
Clinicians, scientists and patients explored whether medical cannabis could help address longstanding inequalities in women’s health.
In a new multi-clinic survey, the majority of patients report improvements in their symptoms.
After two years of Germany’s Cannabis Act (CanG), the most comprehensive analysis of its impact to date has been published.
The Hannah Deacon Campaign is calling on the government to support children unable to access medical cannabis on the NHS.
A comprehensive guide on how to read and interpret cannabis research.
A balanced CBD and THC cannabis flower was found to be more effective for treating acute migraine symptoms than a placebo.
The company is preparing to reach a major regulatory milestone and bring its lead product to market in early 2026.
